One Case of Tinnitus and Hearing Loss Induced by Moxifloxacin Hydrochloride

doi:10.19803/j.1672-8629.2019.12.13

Abstract

CLC Number:

R994.11

QU Gguanghong, LI Jinfeng, LI Fengjun, ZHANG Yuan. One Case of Tinnitus and Hearing Loss Induced by Moxifloxacin Hydrochloride[J]. Chinese Journal of Pharmacovigilance, 2019, 16(12): 765-766.

[1] 贺璐,王国鹏,彭哲,等译.耳鸣临床应用指南[J].听力学及言语疾病杂志, 2015, 23(2):116-139.
[2] 邬丹莲,陈志高,窦文琴.45例莫西沙星不良反应病例分析[J].中国药物警戒, 2013, 13(1):42-44.
[3] FDA. Will you have Tinnitus with Moxifloxacin hydrochloride from FDA reports[EB/OL]. (2019-01-10)[2019-02-10].https://www.ehealthme.com/ds/moxifloxacin-hydrochloride/tinnitus/
[4] Onoh A, Linnebur SA, Fixen DR.Moxifloxacin-induced tinnitus in an older adult[J],Ther Adv Drug Saf. 2018,9(4):219-221.
[5] 廖日洪. 盐酸莫西沙星(拜复乐)致耳鸣1例[J].临床肺科杂志,2009, 14(3):414.
[6] 周丽华,许红蕾.莫西沙星注射液致耳鸣、听力下降、视力模糊不良反应1例[J].药物流行病学杂志, 2016,25(2):129-130.
[7] 黄月莹,高欣涛,刘弘.盐酸莫西沙星注射液致听力、视力损伤1例[J].中国药师, 2016, 19(2):334.
[8] 赵生俊,范芳芳.莫西沙星致不良反应2例[J].中国新药与临床杂志, 2009, 28(6):467-468.
[9] Guitton M J, Caston J, Ruel J,et al.Salicylate induces tinnitus through activation of cochlear NMDA receptors[J]. J Neurosci,2003, 23(9):3944-3952.
[10] Guitton M J, Dudai Y.Blockade of cochlear NMDA receptors prevents long-term tinnitus during a brief consolidation window after acoustic trauma[J]. Neural Plast, 2007,2007:80904.
[11] Eggermont J J.Pathophysiology of tinnitus. an excellent summary of current knowledge about the neural correlates of tinnitus[J]. Prog Brain Res, 2007(166):19-35.
[12] Ball P.Adverse drug reactions:implications for the development of fluoroquinolones[J]. J Antimierob Chemother,2003, 51(11):21-27.
[13] 刘辉,孙锋钢.盐酸莫西沙星导致视幻觉[J].药物不良反应杂志, 2008,10(2):141-142.
[14] 周冰,张俊,张黎明. 93例莫西沙星致严重不良反应报告分析[J].中国药物警戒, 2011, 8(11):696-698.

[1]	SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131.
[2]	ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136.
[3]	BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140.
[4]	JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166.
[5]	LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
[6]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[7]	ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
[8]	WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194.
[9]	LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198.
[10]	XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
[11]	GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207.
[12]	FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210.
[13]	LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
[14]	CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
[15]	ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.

One Case of Tinnitus and Hearing Loss Induced by Moxifloxacin Hydrochloride

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics